NETRI

✨ A historic moment for NETRI! ✨ Yesterday morning, we had the immense pleasure of inaugurating our new factory in the heart of Lyon's Gerland Biodistrict, in the brand-new Bioserra 3 building, and announcing our latest fundraising round. This ambitious project marks a key milestone for NETRI, organs-on-chip and the future of medical research. 📢 A three-stage inauguration: 📰 9:30am - 11am | Press conference with Bruno Bonnell and Matthieu Heslouin, and more than 10 media present. 💬 11h - 12h | Round table discussion moderated by Olivia Cuir, with fascinating exchanges between Thibault Honegger, Florian Larramendy, Bruno Bonnell, Stéphanie PERNOD, Matthieu Heslouin and Olivier Chabanon. 🥂 12pm - 2pm | Cocktails and visits of our production unit. 💡 Over 250 people were on hand to discover this new infrastructure that will revolutionize drug development and accelerate innovation in healthcare. 🔥 A big thank you to all the speakers, to the Esprit des Sens team, to the participants and partners who make this adventure possible! But above all, a big thank you to the NETRI teams, who were able to turn NETRI into this industrial start-up which, in just 18 months, has taken up the challenge of industrialization. Together, we're building the future of medical research. 📸 Flashbacks and replay of the round table will be coming soon...

Only 1 day before our webinar on Profiling Pharmacokinetics (PK) In A Microfluidic Platform. In oncology drug development and assessment, pharmacokinetic (PK) profiles dictate success or failure. Yet, traditional models—in silico, in vitro, and in vivo—they altogether display limitations: ethical concerns, interspecies variability, followed by high failure rates in clinical translation. What if we could replicate diverse PK profiles in vitro, fine-tune therapeutic schedules, and minimize reliance on animal models? 🧪 Join us for an exclusive webinar on Profiling Pharmacokinetics (PK) In A Microfluidic Platform, where we introduce a game-changing approach: ✅ Customizable PK simulations for monotherapies & combinations ✅ Automated, pumpless, and mixerless liquid handling ✅ Long-term treatment schedules (7-21+ days) with washout options ✅ Streamlined sample collection for dynamic & endpoint assays 💡 This platform is set to redefine preclinical oncology research, enhancing predictability, efficiency, and ethical standards. 📅 Tuesday, February 18 ⏲️ 5-6 p.m. (French Time) 🔗 Register now and be part of the future of PK profiling : https://lnkd.in/eqbrMu76 Thibault Honegger Thierry Poumeyrol Benoît Maisonneuve - PhD Tudor Petreus Nassiba Bagdadi

🚀 Il y a près de dix jours, nous avons eu l’honneur d’inaugurer notre nouvelle usine, un site industriel à la hauteur de nos ambitions : révolutionner le développement de médicaments et accélérer l’innovation dans la santé. Cette étape clé pour NETRI a attiré l’attention des médias, et nous sommes fiers de voir notre vision et notre impact relayés dans la presse. Merci aux journalistes qui ont mis en lumière notre start-up industrielle, nos équipes et nos ambitions ! 📢 Découvrez les articles qui parlent de nous et les replays de nos interviews/reportages : 🔗”Quelques cellules et des électrodes : comment les organes sur puce veulent révolutionner la recherche médicale” – Le Figaro, Stéphany Gardier 🔗”NETRI industrialise à Gerland sa production d’organes sur puce” – Tribune de Lyon, David Gossart 🔗”NETRI se dote d’une usine pour ses organes humains reproduits sur puces” – Les Echos, Stéphane Frachet 🔗”A Gerland, la première usine française d’organes-sur-puce accélère la recherche médicale” – Le Tout Lyon, @Séverine RENARD 🔗”A Lyon, NETRI inaugure sa première usine pour ses “organes-sur-puces” destinés à l’industrie pharmaceutique” – L'Usine Nouvelle, Stéphane Frachet 🔗”Santé : NETRI industrialise sa technologie qui simule la réponse des organes avec l’IA” – La Tribune Auvergne-Rhône-Alpes, Emma Rodot et Marie LYAN 🔗”Lyon : des puces pour tester les médicaments du futur” – Ma Santé, Pascal Auclair 🔗”NETRI inaugure son usine d’organes sur puce et lève à nouveau des fonds” – Bref Eco 🔗”NETRI inaugure sa première usine “d’organes sur puce” pour la recherche médicale et lève 5 millions d’euros” – Le Journal des Entreprises, Delphine Sauzay 🔗”Pour tester les médicaments, NETRI inaugure la première usine française d’organes-sur-puce”  – Le Progrès, @S.MONTARON 🔗”Pour tester les médicaments, NETRI inaugure la première usine française d’organes-sur-puce” – Le Dauphiné Libéré, S.MONTARON 🔗”Pourquoi le Lyonnais NETRI se voit comme une future licorne” – LYON DECIDEURS, Cyril Michaud 🔗”NETRI s’innerve à des familly offices” – CFNEWS (Corporate Finance News), Lucas Djeffal 🎥 @Lyon Business BFM Business du mardi 4 février : de 2:34 à 9:50 min. 🎥Ici 19/20 France 3 Auvergne Rhône-Alpes : de 12:24 à 14:51 min. Merci à toutes les équipes NETRI, à nos partenaires notamment Esprit des Sens et à tous ceux qui croient en notre projet. L’histoire ne fait que commencer ! 🚀✨ https://lnkd.in/e2ZhYKhw Thibault Honegger Florian Larramendy

[WEBINAR] In oncology drug development and assessment, pharmacokinetic (PK) profiles dictate success or failure. Yet, traditional models—in silico, in vitro, and in vivo—they altogether display limitations: ethical concerns, interspecies variability, followed by high failure rates in clinical translation. What if we could replicate diverse PK profiles in vitro, fine-tune therapeutic schedules, and minimize reliance on animal models? 🧪 Join us for an exclusive webinar on Profiling Pharmacokinetics (PK) In A Microfluidic Platform, where we introduce a game-changing approach: ✅ Customizable PK simulations for monotherapies & combinations ✅ Automated, pumpless, and mixerless liquid handling ✅ Long-term treatment schedules (7-21+ days) with washout options ✅ Streamlined sample collection for dynamic & endpoint assays   💡 This platform is set to redefine preclinical oncology research, enhancing predictability, efficiency, and ethical standards. 📅 Tuesday, February 18 ⏲️ 5-6 p.m. (French Time) 🔗 Register now and be part of the future of PK profiling : https://lnkd.in/eqbrMu76 Thibault Honegger Thierry Poumeyrol Benoît Maisonneuve - PhD Tudor Petreus Nassiba Bagdadi

🔬✨ International Day of Women and Girls in Science ✨🔬   At NETRI, we believe that innovation thrives when diversity is at its core. On this International Day of Women and Girls in Science, we celebrate the incredible contributions of women who push the boundaries of knowledge and technology every day.   At NETRI, we are committed to fostering an inclusive environment where talented women scientists can lead, innovate, and inspire. Because science is stronger when everyone has a seat at the table.   💡 To all the brilliant women in science and all the scientists at NETRI - your work shapes the future, thank you.

✨ Un moment historique pour NETRI ! ✨ Ce matin, nous avons eu l'immense plaisir d’inaugurer notre nouvelle usine au cœur du Biodistrict de Gerland, à Lyon, dans le tout nouveau bâtiment Bioserra 3, et d'annoncer notre dernière levée de fonds. Un projet ambitieux qui marque une étape clé pour NETRI, les organes sur puce et pour l'avenir de la recherche médicale. 📢 Une inauguration en trois temps : 📰 9h30 - 11h | Conférence de presse avec Bruno Bonnell et Matthieu Heslouin, ainsi que plus de 10 médias présents. 💬 11h - 12h | Table ronde animée par Olivia Cuir, avec des échanges passionnants entre Thibault Honegger, Florian Larramendy, Bruno Bonnell, Stéphanie PERNOD, Matthieu Heslouin et Olivier Chabanon. 🥂 12h - 14h | Cocktail et visites de notre unité de production. 💡 Plus de 250 personnes étaient présentes pour découvrir cette nouvelle infrastructure qui va révolutionner le développement de médicaments et accélérer l’innovation dans la santé. 🔥 Un grand merci à tous les intervenants, à l'équipe Esprit des Sens, aux participants et partenaires qui rendent cette aventure possible ! Mais surtout, un grand merci aux équipes NETRI, qui ont su faire de NETRI cette start-up industrielle qui, en seulement 18 mois, a relevé le challenge de l'industrialisation. Ensemble, nous bâtissons l’avenir de la recherche médicale. 📸 Des retours en images et un replay de la table ronde à venir…

Only 1 day before our live demonstration of how we digitize human biology to predict the effect of a drug or compound candidate with our platform NeuroFluidics Care. 📅 Thursday, January 23 ⏲️ 5-6 p.m. (French Time) 📍 Online: https://lnkd.in/e4ZzdDXE Thibault Honegger Serge Roux Thierry Poumeyrol

JP Morgan Week | Day 2 Our CEO & Co-founder Thibault Honegger will be present in San Francisco at the French Corner (8th Floor, 26 O'Farrell Street San Francisco, CA 94108) until Thursday January 16. Want to know more about our Neurons as a Senor #NaaS platform to accelerate drug discovery and preclinical phases? Book a meeting with Thibault Honegger via the Biopartnering platform or directly with his shared calendar. www.netri.com

#CES2025 in Las Vegas was a blast. The 4 days were filled with very interesting exchanges around our platform, which digitizes human biology to predict the effect of a drug or compound candidate. And for those who weren't there, we invite you to our 10th webinar and the 1st in the 2025 series for a live demonstration of our Innovation Award-winning solution, NeuroFluicis Care. 📅 Thursday, January 23 ⏲️ 5-6 p.m. (French Time) 📍 Online: https://lnkd.in/e4ZzdDXE Thibault Honegger Serge Roux Thierry Poumeyrol

The CES 2025 was a blast. Now it's off to San Francisco for our CEO & Co-founder Thibault Honegger for JP Morgan Week. Go to Biopartnering platform to book a meeting with Thibault Honegger and to Business France's French Corner, 8th Floor, 26 O'Farrell Street San Francisco, CA 94108, to meet us.